ID-93

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameID-93
Drug Alias NameTuberculosis vaccine recombinant Mycobacterium tuberculosis protein ID93/adjuvant GLA-SE (Aeras/IDRI)Tuberculosis-vaccine-recombinant-Mycobacterium-tuberculosis-protein-ID93 (Aeras/IDRI)Tuberculosis-vaccine-ID93 (Aeras/IDRI)Tuberculosis vaccine adjuvanted (Aeras/IDRI)ID-93 +[10] 
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalariaTuberculosis, PulmonaryTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth AfricaUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInfectious Disease Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesInfectious Disease Research InstituteAerasUniversity Of Oxford +[4] 
Inactive CompaniesAccess to Advanced Health InstituteQuratis Inc
Active IndicationsMalariaTuberculosis, PulmonaryTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A